Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Immunology: An Alternative Route to Inflammation

March 31, 2016 8:42 am | by Ludwig-Maximilians Universitat Munchen | News | Comments

Scientists have defined a previously unknown pathway that triggers inflammation. Read more...

TOPICS:

Japan Approves Marketing Authorization for GSK's Nucala

March 31, 2016 8:37 am | News | Comments

Approval in Japan comes just four months after the approval of Nucala in the US. Read more...

TOPICS:

New Drug Shows Promise Against Muscle-Wasting Disease

March 31, 2016 8:31 am | by University College London | News | Comments

IBM is the most common muscle disease in people over 45. Read more...

TOPICS:
Advertisement

Nonpathogenic Viruses Transferred During Fecal Transplants

March 30, 2016 11:21 am | by American Society for Microbiology | News | Comments

Immunities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Read more..

TOPICS:

New Tool Mines Whole-Exome Sequencing Data to Match Cancer with Best Drug

March 30, 2016 11:11 am | by University of Colorado | News | Comments

A University of Colorado Cancer study published today in the Journal of the American Medical Informatics Association (JAMIA) describes a new tool that interprets the raw data of whole exome tumor sequencing and then matches the cancer's unique genetics to FDA-approved targeted treatments. Read more..

Gov't Panel Backs Drug for Delusions in Parkinson's Patients

March 30, 2016 10:56 am | by Matthew Perrone, AP Health Writer | News | Comments

Federal health experts have endorsed an experimental drug intended to treat psychotic delusions and behaviors that often afflict patients with Parkinson's disease, the debilitating movement disorder. Read more...

TOPICS:

Nanoparticles Deliver Anticancer Cluster Bombs

March 30, 2016 10:46 am | by Emory Health Sciences | News | Comments

Scientists have devised a triple-stage "cluster bomb" system for delivering the chemotherapy drug cisplatin, via tiny nanoparticles designed to break up when they reach a tumor. Read more..

TOPICS:

Sanofi Pasteur: Strategy for 2nd-Gen Influenza Vaccine

March 30, 2016 10:38 am | News | Comments

Sanofi Pasteur, the vaccines division of Sanofi, announces published data on a vaccine strategy that elicited a broadly-reactive response against seasonal and pandemic H1N1 influenza viruses in mice. Read more..

TOPICS:
Advertisement

Blood Test for Concussions? Researchers Report Some Progress

March 30, 2016 10:17 am | News | Comments

New research bolsters evidence that a simple blood test may someday be used to detect concussions. Read more..

TOPICS:

WHO: Ebola No Longer World Health Emergency

March 30, 2016 8:33 am | by Krista Larson, Associated Press | News | Comments

The announcement puts an end to the international emergency declaration that has been controversial. Read more...

TOPICS:

Discovery Offers Key for Combating Muscular Dystrophy

March 30, 2016 8:32 am | by Kobe University | News | Comments

Muscular dystrophy is an incurable genetic condition marked by progressive weakening of the muscles. Read more...

TOPICS:

WHO: More Oversight Needed after China's Vaccine Scandal

March 30, 2016 8:31 am | by Louise Watt, Associated Press | News | Comments

The scandal reinforces long-standing public concerns over the safety of China's food and medicine supply. Read more...

TOPICS:

UGA, Sanofi Develop New Flu Vaccine

March 30, 2016 8:31 am | by University of Georgia | News | Comments

The H1N1 influenza virus caused a worldwide pandemic in 2009. Read more...

TOPICS:

U.S. Firms Target Investment in Israeli Cannabis R&D

March 30, 2016 8:30 am | by Maayan Lubell, Reuters | News | Comments

Israel is starting to attract American companies looking to bring medical marijuana know-how to a booming market back home. Read more...

TOPICS:

Meet Sanofi's Newest R&D Chief

March 30, 2016 8:23 am | by Ryan Bushey, Digital Editor | News | Comments

A top scientist at AstraZeneca has left the company to join the French drug maker. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading